Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

Israel · Delayed Price · Currency is ILS · Price in ILA

1,141.00

-31.00 (-2.65%)

Mar 31, 2026, 5:24 PM IDT

Revenue by Segment

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Core Products	227.33M	224.46M	189.51M	160.74M	170.12M
Core Products Growth	1.28%	18.44%	17.90%	-5.52%	43.10%
Distribution	77.25M	81.59M	87.19M	88.36M	81.42M
Distribution Growth	-5.32%	-6.41%	-1.33%	8.53%	36.80%
Other	17.13M	15.61M	15.69M	14.86M	13.94M
Other Growth	9.77%	-0.55%	5.64%	6.60%	-23.00%
Total	321.71M	321.66M	292.39M	263.95M	265.47M
Total Growth	0.02%	10.01%	10.78%	-0.57%	35.10%

Revenue by Geography

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Israel	321.71M	321.66M	292.39M	263.95M	265.47M
Israel Growth	0.02%	10.01%	10.78%	-0.57%	35.10%
Total	321.71M	321.66M	292.39M	263.95M	265.47M
Total Growth	0.02%	10.01%	10.78%	-0.57%	35.10%

Source: S&P Global Market Intelligence.